BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 6327016)

  • 1. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of glutamine-phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14).
    Prajda N; Katunuma N; Morris HP; Weber G
    Cancer Res; 1975 Nov; 35(11 Pt 1):3061-8. PubMed ID: 241484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver.
    Heinrich PC; Morris HP; Weber G
    Cancer Res; 1976 Sep; 36(9 pt.1):3189-97. PubMed ID: 10080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy.
    Rizzo MT; Weber G
    Cancer Res; 1994 May; 54(10):2611-4. PubMed ID: 8168087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
    Natsumeda Y; Ikegami T; Olah E; Weber G
    Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation-linked increase in phosphoribosylformylglycinamidine synthetase activity (EC 6.3.5.3).
    Elliott WL; Weber G
    Cancer Res; 1984 Jun; 44(6):2430-4. PubMed ID: 6722784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).
    Prajda N; Morris HP; Weber G
    Cancer Res; 1976 Dec; 36(12):4639-46. PubMed ID: 187329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation- and malignancy-linked signal transduction enzyme.
    Singhal RL; Prajda N; Yeh YA; Weber G
    Cancer Res; 1994 Nov; 54(21):5574-8. PubMed ID: 7923199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
    J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development--their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome.
    Allsop J; Watts RW
    J Neurol Sci; 1980 May; 46(2):221-32. PubMed ID: 6155447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.
    Baló-Banga JM; Weber G
    Cancer Res; 1984 Nov; 44(11):5004-9. PubMed ID: 6091867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine enzymology of human colon carcinomas.
    Natsumeda Y; Lui MS; Emrani J; Faderan MA; Reardon MA; Eble JN; Glover JL; Weber G
    Cancer Res; 1985 Jun; 45(6):2556-9. PubMed ID: 3986794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine synthetic capacities of de novo and salvage pathways in rat hepatoma 3924A cells.
    Natsumeda Y; Ikegami T; Weber G
    Adv Exp Med Biol; 1986; 195 Pt B():371-6. PubMed ID: 3094327
    [No Abstract]   [Full Text] [Related]  

  • 15. Purine metabolic cycle in normal and leukemic leukocytes.
    Dietz AA; Czebotar V
    Cancer Res; 1977 Feb; 37(2):419-26. PubMed ID: 188545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine salvage enzyme activities in normal and neoplastic human tissues.
    Camici M; Tozzi MG; Allegrini S; Del Corso A; Sanfilippo O; Daidone MG; De Marco C; Ipata PL
    Cancer Biochem Biophys; 1990 Jul; 11(3):201-9. PubMed ID: 2125239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased uridine kinase (ATP: uridine 5'-phosphotransferase; EC 2.7.1.48) activity in human and rat tumors.
    Shen F; Look KY; Yeh YA; Weber G
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):1-15. PubMed ID: 9923963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymes of the pathway of purine synthesis in the rat mammary gland. Changes in the lactation cycle and the effects of diabetes.
    Beardsley S; Kunjara S; Greenbaum AL
    Biochem J; 1988 Mar; 250(2):395-9. PubMed ID: 2451510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
    Sanfilippo O; Camici M; Tozzi MG; Turriani M; Faranda A; Ipata PL; Silvestrini R
    Cancer Biochem Biophys; 1994 Apr; 14(1):57-66. PubMed ID: 7796389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.